Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Orthofix Medical Stock Quote

Orthofix Medical (NASDAQ: OFIX)

$13.09
(-1.7%)
-$0.23
Price as of April 15, 2024, 4:00 p.m. ET

Orthofix Medical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
OFIX -28.27% -75.19% -24.33% +27%
S&P +23.57% +76.22% +11.98% +1,138%

Orthofix Medical Company Info

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.